Latest From Bob Kronemyer
Perrigo Reaches Year Anniversary For First OTC Brand Switch With Sixth Packaging Approval
Latest FDA approval for mometasone furoate, 50-mcg metered spray, is for three 144-spray containers. Nasonex 24HR Allergy is Perrigo’s first OTC switch of national brand and first mometasone furoate offered nonprescription in US.
Perrigo Plays Customary Card For Approval Of First OTC Ibuprofen-Acetaminophen Generic In US
First generic of Haleon Advil Dual Action approved as brand lost three-year market exclusivity and day after Perrigo announced end of phase 1 of turnaround strategy and start of starting phase 2.
Health Care Professionals Settle With FTC Over COVID-19 Claims For Direct Seller’s Supplements
Three distributors made claims doTerra's essential oils and supplements could treat or prevent COVID-19 in early 2022webinars. They also underscored medical expertise in recommending products.
Science Groups’ Petition Says Ban On Red 3 Dye In Food, Supplements, Drugs ‘Statutorily Obligated’
Studies find color additive carcinogenic in humans and animals and linked to neurobehavioral disorders in some children. Dye alternatives available. One of petition authors, CSPI, doubts FDA will meet deadline for its decision.
Herbalife Relaunches To ‘2.0’ With 'Unified, Global Platform' After Sales Fall 10.3% In 2022
Direct seller announces relaunch after year-long sales slump blamed on macroeconomic inflationary pressures. No full-year guidance due to rapidly shifting macroeconomic environment and increased market volatility.
Bee Gone Children’s Nasal Swab Warning Aligns With US FDA Homeopathic Enforcement Priority
Buzzagogo’s allergy relief nasal swab found contaminated with bacillus species, leading to voluntary recall of homeopathic remedy indicated for use by children as young as 1.